Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article reviews in vitro methods for evaluating whitening, anti-wrinkle, and hair growth ingredients in cosmetics, noting that more human-relevant evaluation methods with reliable biomarkers are needed; it presents no new clinical outcomes.

This study found that oral cyclosporine combination therapy led to new hair growth in 71% of patients with severe and refractory alopecia areata, though mild and transient side effects were common.

This study found that oral minipulse therapy with betamethasone may effectively promote hair regrowth in alopecia areata while causing fewer severe side effects compared to traditional pulse therapy.

This study reports that oral minipulse therapy with betamethasone was effective in promoting hair regrowth and managing alopecia areata with fewer side effects than traditional pulse therapies.

This study analyzed 1505 patients with various forms of alopecia over 20 years, finding alopecia areata to be the most common type, followed by androgenetic alopecia and telogen effluvium.

This study found that trichotillomania was more common in younger people, particularly females, and was characterized by increased catagen hair without perifollicular inflammation.

This study aimed to explore the relationship between stress and dermatologic disorders and found that the connection remains unclear, but it also examined the potential influence of coping strategies.

This study concluded that bundle hair grafting was an effective and safe treatment method for patients with androgenetic alopecia, providing excellent cosmetic satisfaction despite some side effects and procedural challenges.

This study found a significantly higher density of Demodex mites in sebaceous hyperplasia lesions compared to controls, suggesting a possible link between Demodex and the development of these skin lesions.

This study found that androgenetic alopecia is significantly associated with a family history of baldness, and most patients showed normal serum testosterone levels.

This study found that women with androgenetic alopecia had significantly higher mean plasma levels of DHEA-S and total testosterone compared to normal females, despite most individuals in both groups being within normal hormonal ranges.

This study found no significant difference in androgen receptor expression between lesional and non-lesional scalp in patients with androgenetic alopecia.

This study found that peanut agglutinin binding patterns after neuraminidase pretreatment can help differentiate malignant melanoma from nevocellular nevus in skin specimens.

This study observed that the proportion of female pattern hair loss among total alopecia cases has significantly increased over the past 20-30 years, with teenage cases rising likely due to earlier puberty.

This study found that a hair tonic containing a human umbilical cord blood mesenchymal stem cell-derived conditioned medium significantly increased hair density, thickness, and growth rate in patients with androgenetic alopecia.

This study found that a 0.5-mm microneedle depth was more effective than 0.3 mm for increasing hair density in AGA patients treated with a topical growth factor cocktail.

This study observed no significant association between early-onset androgenetic alopecia and medical comorbidities in the Korean population.

This article reviews the impact of dutasteride on hair growth in androgenetic alopecia, finding it significantly increases hair count and width compared to finasteride and placebo, but reports no new results.

This study found that micropigmentation effectively improved the cosmetic appearance of scalp and eyebrow scars in 94% of patients, with the pigments remaining safely in the superficial dermis after one year.

This study reported that almost 25% of women with PCOS were diagnosed with NAFLD, and 32.7% to 44.6% had metabolic syndrome, with higher prevalence in those with both conditions.

This study found that chemotherapy-induced alopecia was more prevalent among women, particularly those with genitourinary and breast cancer, and over half of affected women used wigs or bonnets to cope.

In this study investigating goat herds in Zambia, both mange and orf were detected, but with low occurrence linked to diagnostic challenges and mild clinical signs; further research, especially in conditions favoring mange mites, is recommended to better understand and manage these diseases.

This article reviews the pathophysiology and limited effectiveness of current treatments for androgenic alopecia, including finasteride, minoxidil, botulinum toxin A, and platelet-rich plasma, and highlights the need for new therapeutic approaches; it reports no new clinical findings.

This study quantified relationships among various occupations in Japan, enabling comparisons with vocational aptitude test results using new numerical criteria developed from analysis of over three million survey panels.

This study found that a herbal medicine increased hair growth in a mouse model, showing strong antioxidant activity and similar 5-alpha-reductase inhibition to finasteride without cytotoxicity in human dermal papilla cells.

In this study, researchers observed that amla extract promoted hair growth by enhancing cell proliferation and reducing 5α-reductase expression in human dermal papilla cells, suggesting it may be effective in preventing hair loss.

This study suggests that specific structural features of minoxidil analogs, such as hydrophobic and hydrogen bond field contributions, are key to enhancing lysyl hydroxylase inhibitory activity, which could inform future hair growth treatments.

Platycodon grandiflorum extracts may help prevent hair loss and fight dandruff.

This study documented that dermatophytosis was highly prevalent in Basra's cats, particularly affecting males and cats under nine months, with lesions most frequent on ears, face, and abdomen.

This study found that switching patients with alopecia areata unresponsive to topical clobetasol 17 propionate 0.05% to anthralin treatment led to improved treatment success.